BAT-8006

N/A

Report date: 2025/07/03 11:48:00

Base Information

Drug NameBAT-8006
Drug Alias NameBAT8006BAT-8006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-FOLR1DNA topoisomerase I inhibitors
TargetsFolate receptor alphaDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursFallopian Tube NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBio-Thera Solutions Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBio-Thera Solutions Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursFallopian Tube NeoplasmsOvarian Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A